Gsk Net Debt Growth & History (GSK)

Gsk's net debt was £11.89B for fiscal 2025.

View full Gsk company overview

Gsk annual net debt history

Gsk annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31£11.89B£1.56B+15.10%
20242024-12-31£10.33B−£2.98B−22.42%
20232023-12-31£13.31B−£1.17B−8.09%
20222022-12-31£14.48B−£2.10B−12.65%
20212021-12-31£16.58B£974.0M+6.24%
20202020-12-31£15.61B−£5.14B−24.79%
20192019-12-31£20.75B£2.98B+16.75%
20182018-12-31£17.77B£8.43B+90.17%
20172017-12-31£9.35B£438.0M+4.92%
20162016-12-31£8.91B£4.01B+81.89%
20152015-12-31£4.90B

Gsk net debt trends

Over the last five fiscal years, Gsk's net debt decreased from £15.61B to £11.89B, a change of −£3.72B. The latest reported quarter, Q2 2026, shows £15.13B.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Gsk source filings ↗

Community posts

It’s quiet here.

No posts about GSK yet. Start the conversation.

Write the first post